Schedule 13D ownership disclosure

KINIKSA PHARMACEUTICALS LTD

Security class unavailable · CUSIP: G5269C101

Event date: 2019-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,031,268
Percent of class
16.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-005387
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Feb 06, 2019
Reporting period
Feb 04, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub